|
FAM72D expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.637700E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.359220E-01 |
| Normal-vs-Stage2 |
7.178900E-03 |
| Normal-vs-Stage3 |
4.916000E-02 |
| Normal-vs-Stage4 |
1.031770E-01 |
| Stage1-vs-Stage2 |
2.02729999999596E-05 |
| Stage1-vs-Stage3 |
9.673500E-02 |
| Stage1-vs-Stage4 |
6.117800E-01 |
| Stage2-vs-Stage3 |
1.088030E-02 |
| Stage2-vs-Stage4 |
1.530270E-02 |
| Stage3-vs-Stage4 |
4.864000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.276580E-01 |
| Normal-vs-AfricanAmerican |
2.034200E-02 |
| Normal-vs-Asian |
8.209600E-02 |
| Caucasian-vs-AfricanAmerican |
1.850050E-02 |
| Caucasian-vs-Asian |
4.543800E-01 |
| AfricanAmerican-vs-Asian |
2.241800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.090000E-02 |
| Normal-vs-Female |
8.570400E-02 |
| Male-vs-Female |
5.135800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.841390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.317900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.703800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.925400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.362800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.111600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.850800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.552400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.301900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.163600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.814800E-01 |
| Classical-VS-Follicular |
1.359280E-03 |
| Classical-VS-Other |
3.433000E-01 |
| Classical-VS-Normal |
1.257250E-01 |
| Tall-VS-Follicular |
7.413900E-02 |
| Tall-VS-Other |
6.658600E-01 |
| Tall-VS-Normal |
1.365980E-01 |
| Follicular-VS-Other |
5.645200E-01 |
| Follicular-VS-Normal |
1.407830E-02 |
| Other-VS-Normal |
6.491500E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.275700E-02 |
| Normal-vs-N1 |
1.061040E-01 |
| N0-vs-N1 |
3.975600E-01 |
|
|
